The Clinical Times
The Front Page of Medicine

Latest medical news · page 241

The latest headlines across every section, pulled from official and open-access sources.

MedlinePlus (NLM) · May 24, 2026

Mental Health Emergency Care

Source: Children's Hospitals and Clinics of Minnesota Related MedlinePlus Pages: Child Mental Health , Emergency Medical Services , Teen Mental Health

MedlinePlus (NLM) · May 24, 2026

Medical Bill Rights

Source: Centers for Medicare & Medicaid Services Related MedlinePlus Pages: Emergency Medical Services , Health Insurance

FDA Recalls · May 22, 2026

SKS Copack Recalls Various Specialty Beverages Because of Possible Health Risk

SKS Copack of Cerritos, CA is recalling various specialty beverages, because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy per

WHO · May 22, 2026

First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda 2026 – Temporary recommendations

The Committee’s advice aligned with the determination by the WHO Director-General that the event constitutes a public health emergency of international concern (PHEIC), but does not meet the criteria for pandemic emergency. The DG, considering the advice of the Committee, he is hereby issuing the following temporary recommendations to all States Parties.

PLOS Medicine · May 22, 2026

Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993–2025: A systematic review and meta-analysis

by Nicole A. Swartwood, Nanki Singh, Seyed Alireza Mortazavi, Melike Hazal Can, Hening Cui, Do Kyung Ryuk, Peter MacPherson, Katherine C. Horton, Nicolas A. Menzies Background Global and national initiatives to combat tuberculosis (TB) have expanded over recent years. Despite this, the TB burden remains high in some population groups, with men recognized as having elevated TB risks. Summary measures of sex differences in TB prevalence were last estimated in 2016. Since then, many additional prevalence surveys have been conducted, including in the highest TB burden countries. We conducted a…

EMA (EU) · May 22, 2026

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026

Eight new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2026 meeting.Jascayd (nerandomilast)…, CHMP statistics Key figures from the May 2026 CHMP meeting are represented in the graphic below.  , CHMP statistics:…, Positive recommendations on new medicines, Boey INN trenibotulinumtoxinE Marketing authorisation applicant AbbVie Deutschland GmbH & Co Therapeutic indication Temporary improvement in the…, Etcamah INN camizestrant Marketing authorisation applicant Astra Zeneca Therapeutic indication…

EMA (EU) · May 22, 2026

New medicine for two types of pulmonary fibrosis

EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or…

← NewerOlder →

Back to the live front page